| Trial | Updated / Type |
Status | Phase | Were Results Reported |
Reported Actual Enrollment |
(MeSH) Terms |
Why Stopped
Limitations And Caveats |
Annotator decisions |
|---|---|---|---|---|---|---|---|---|
| NCT00369538 Details | 2009-02-18 Interventional | 4 | - | Hydrochlorothia… Losartan Hypertension Kidney Diseases Kidney Failure,… Proteinuria End Stage Renal… | principle investigator moved, new investigators will join, insurance expired - project needs to
be re-examined by an ethic committee - | |||
| NCT00477802 Details | 2009-02-16 Interventional | 4 | 8 | Botulinum Toxin… Botulinum Toxin… abobotulinumtox… Dyskinesias Parkinson Disea… | Intervention did not appear to be effective in most enrolled patients. - | |||
| NCT00315601 Details | 2009-02-13 Interventional | 4 | 35 | Azithromycin Dimercaprol Telithromycin Healthy | Sanofi-Aventis wanted the study terminated. - | |||
| NCT00129870 Details | 2009-02-13 Interventional | 4 | 180 | Oxaliplatin Colorectal Neop… Colorectal Canc… | Unplanned interim analysis by DSMB indicated possible reduced response rate with the addition
of Ca/Mg in pooled population. Further analysis pending. - | |||
| NCT00668356 Details | 2009-02-09 Interventional | 2 | - | Didanosine HIV Infections | questions of the benefit efficacy/risks of ddI during the meal not resolved - | |||
| NCT00327093 Details | 2009-02-09 Interventional | 4 | 31 | Bevacizumab Cetuximab Colorectal Neop… Neoplasm Metast… Colorectal Canc… | The scientific commitee decided to stop the inclusions and exploit the results. - | |||
| NCT00190034 Details | 2009-02-09 Interventional | 4 | - | Acetylcysteine N-monoacetylcys… Acute Kidney In… Cardiovascular … Renal Insuffici… Cardiopulmonary… Cardiovascular … Renal Insuffici… | opposite result - | |||
| NCT00003067 Details | 2009-02-09 Interventional | 2 | [1 Refs] | - | Aldesleukin Central Nervous… Glioma Nervous System … Brain and Centr… | - - | ||
| NCT00419549 Details | 2009-01-29 Interventional | 2/3 | 371 | Valdecoxib Pancreatitis ERCP | Because one of the drugs Valdecoxib was withdrawn due to safety concerns. - | |||
| NCT00557921 2007-005891-15 Details | 2009-01-28 Interventional | 3 | - | Aspirin Clopidogrel Omeprazole Acute Coronary … Coronary Artery… Infarction Myocardial Infa… Percutaneous Co… | Terminated by Sponsor - | |||
| NCT00294749 2005-005959-17 Details | 2009-01-27 Interventional | 3 | - | Ciprofloxacin Prostatic Neopl… Men Who Must Un… | - - | |||
| NCT00203190 Details | 2009-01-23 Interventional | 4 | - | Topiramate Cluster Headach… Headache | - - | |||
| NCT00365222 Details | 2009-01-22 Interventional | 2 | 1 | Temozolomide Glioblastoma Gliosarcoma | IRB Study Closure - | |||
| NCT00298012 2005-001202-60 Details | 2009-01-05 Interventional | 4 | - | Methotrexate Axial Spondyloa… Spondylarthriti… Spondylarthropa… Spondylitis Spondylitis, An… | - - | |||
| NCT00397709 Details | 2008-12-31 Interventional | 4 | - | Isoniazid Rifampin Infections Latent Tubercul… Tuberculosis | - - | |||
| NCT00810706 Details | 2008-12-18 Interventional | 3 | [2 Refs] | 448 | Exemestane Breast Neoplasm… Breast Cancer | Publication of MA17 results (similar trial in the extented adjuvant setting with letrozole) - | ||
| NCT00235651 Details | 2008-12-17 Interventional | 3 | - | Amphotericin B Liposomal ampho… Lung Diseases Lung Transplant… | study completed - | |||
| NCT00177749 Details | 2008-12-17 Interventional | 4 | - | Posaconazole Communicable Di… Infections Invasive Fungal… Mycoses Fungal Infectio… | Study is complete Analysis is complete - | |||
| NCT00171119 Details | 2008-12-17 Interventional | 4 | 81 | Valsartan Diabetes Mellit… Diabetic Nephro… Hypertension Diabetic Nephro… | - - | |||
| NCT00324025 NCT00804635 Details | 2008-12-12 Interventional | 2 | 3 | Efungumab Meningitis Meningitis, Cry… Cryptococcal Me… | - - |